Partner Headlines - BCRX

  1. Benzinga's Top Downgrades

    Benzinga
  2. Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals ...

    Benzinga
  3. Mid-Day Market Update: Dow Tumbles Over 350 Points; Apollo Education ...

    Benzinga
  4. Mid-Morning Market Update: Markets Open Lower; Hasbro Beats Q4 ...

    Benzinga
  5. BioCryst Pharmaceuticals Is Plummeting 65%

    Benzinga
  6. Biocryst Pharmaceuticals Says Oral Administration Of Avoralstat ...

    Benzinga
  7. 10 Stocks Moving In Tuesday's Pre-Market Session

    Benzinga
  8. Benzinga's Top Downgrades

    Benzinga
  9. Morning Market Losers

    Benzinga
  10. US Stock Futures Down Ahead Of Fed Minutes

    Benzinga
  11. BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

    Benzinga
  12. Robert Ingram Named to BioCryst's Board of Directors

    Benzinga
  13. 6 Movers To Keep An Eye On Next Week

    Benzinga
  14. FedBizOpps Reporting Biocryst Received $12,133,606 For BCX443 ...

    Benzinga
  15. Benzinga's Top Upgrades

    Benzinga
  16. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga
  17. Tekmira falls on Ebola news

    IBD
  18. Tekmira Tumbles On Ominous Signs For Ebola Drug

    IBD
  19. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga
  20. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  21. BioCryst Announces Initiation of a Phase 1 Clinical Trial of ...

    Benzinga
  22. Benzinga's Top Initiations

    Benzinga
  23. Benzinga's Top Upgrades

    Benzinga
  24. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected ...

    Benzinga
  25. Benzinga's Top #PreMarket Gainers

    Benzinga
  26. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  27. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  28. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  29. BioCryst Pharmaceuticals'

    IBD
  30. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga
  31. Benzinga's Top #PreMarket Gainers

    Benzinga
  32. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  33. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  34. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals ...

    Benzinga
  35. Ebola Vaccine Contenders

    Benzinga
  36. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  37. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  38. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  39. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  40. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  41. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  42. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga
  43. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  44. Benzinga's Top #PreMarket Gainers

    Benzinga
  45. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 ...

    Benzinga
  46. Making Money With Charles Payne: 10/0614

    FoxBusiness
  47. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD
  48. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  49. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement ...

    Benzinga
  50. Markets Open Higher; Hewlett-Packard Plans To Split Into Two ...

    Benzinga
  51. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  52. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  53. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  54. Morning Market Movers

    Benzinga
  55. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  56. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat ...

    Benzinga
  57. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga
  58. BioCryst Receives Additional NIAID Funding For Manufacture and ...

    Benzinga
  59. Momentum Stocks Showing Weakness

    Benzinga
  60. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  61. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  62. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  63. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  64. Biotechs That Might Benefit From Ebola

    Benzinga
  65. Benzinga's Top #PreMarket Gainers

    Benzinga
  66. Stocks Hitting 52-Week Highs

    Benzinga
  67. Benzinga's Top Initiations

    Benzinga
  68. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  69. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  70. Ebola Stocks Continue Higher

    Benzinga
  71. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  72. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  73. Benzinga's Top Initiations

    Benzinga
  74. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  75. Benzinga's Top #PreMarket Gainers

    Benzinga
  76. Benzinga's Top Downgrades

    Benzinga
  77. Benzinga's Top Initiations

    Benzinga
  78. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  79. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  80. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  81. Benzinga's Top #PreMarket Gainers

    Benzinga
  82. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  83. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  84. Benzinga's Top Pre-Market Gainers

    Benzinga
  85. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  86. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  87. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  88. Benzinga's Top Pre-Market Gainers

    Benzinga
  89. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  90. Benzinga's Top Pre-Market Gainers

    Benzinga
  91. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  92. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  93. Benzinga's Top Pre-Market Losers

    Benzinga
  94. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  95. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  96. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  97. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  98. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  99. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  100. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
Trading Center